AJANTA PHARMA
Back to Income Statement
|
AJANTA PHARMA Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹4,209 Cr | ₹3,743 Cr | ₹3,341 Cr | ₹2,890 Cr | ₹2,588 Cr |
What is the latest Revenue of AJANTA PHARMA ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹4,209 Cr |
| Mar2024 | ₹3,743 Cr |
| Mar2023 | ₹3,341 Cr |
| Mar2022 | ₹2,890 Cr |
| Mar2021 | ₹2,588 Cr |
How is Revenue of AJANTA PHARMA Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹4,209 Cr | 12.45 | |
| Mar2024 | ₹3,743 Cr | 12.02 | |
| Mar2023 | ₹3,341 Cr | 15.62 | |
| Mar2022 | ₹2,890 Cr | 11.66 | |
| Mar2021 | ₹2,588 Cr | - | |
Compare Revenue of peers of AJANTA PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AJANTA PHARMA | ₹36,073.0 Cr | 6.9% | -3.5% | 12.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹407,083.0 Cr | -3.9% | -8.9% | -3.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹163,971.0 Cr | 3.8% | -4.7% | 11.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹140,660.0 Cr | 3.2% | -5.6% | 26.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,686.0 Cr | 3.3% | -6% | 11% | Stock Analytics | |
| CIPLA | ₹99,086.7 Cr | 0.8% | -9.1% | -13.1% | Stock Analytics | |
AJANTA PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AJANTA PHARMA | 6.9% |
-3.5% |
12.6% |
| SENSEX | 4.7% |
-0.1% |
3.6% |
You may also like the below Video Courses